ArticleEvidence-based complementary and alternative medicine : eCAM2022

An ALBI- and Ascites-Based Model to Predict Survival for BCLC Stage B Hepatocellular Carcinoma.

Cheng He et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.